NO176162C - Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse - Google Patents

Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse

Info

Publication number
NO176162C
NO176162C NO882565A NO882565A NO176162C NO 176162 C NO176162 C NO 176162C NO 882565 A NO882565 A NO 882565A NO 882565 A NO882565 A NO 882565A NO 176162 C NO176162 C NO 176162C
Authority
NO
Norway
Prior art keywords
preparation
delivery device
drug delivery
controlled drug
coating
Prior art date
Application number
NO882565A
Other languages
English (en)
Other versions
NO176162B (no
NO882565D0 (no
NO882565L (no
Inventor
Gautam Ramchandra Ranade
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO882565D0 publication Critical patent/NO882565D0/no
Publication of NO882565L publication Critical patent/NO882565L/no
Publication of NO176162B publication Critical patent/NO176162B/no
Publication of NO176162C publication Critical patent/NO176162C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/05—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating specially adapted to be released by contact with a liquid, e.g. for toilets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extrusion Moulding Of Plastics Or The Like (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Communication Control (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
  • Saccharide Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO882565A 1987-06-11 1988-06-10 Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse NO176162C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/061,925 US4792448A (en) 1987-06-11 1987-06-11 Generic zero order controlled drug delivery system

Publications (4)

Publication Number Publication Date
NO882565D0 NO882565D0 (no) 1988-06-10
NO882565L NO882565L (no) 1988-12-12
NO176162B NO176162B (no) 1994-11-07
NO176162C true NO176162C (no) 1995-02-15

Family

ID=22039041

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882565A NO176162C (no) 1987-06-11 1988-06-10 Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse

Country Status (26)

Country Link
US (1) US4792448A (no)
EP (1) EP0294993B1 (no)
JP (1) JPH0688900B2 (no)
KR (1) KR900004092B1 (no)
CN (1) CN1018151B (no)
AT (1) ATE64850T1 (no)
AU (1) AU598938B2 (no)
CA (1) CA1326821C (no)
CS (1) CS274431B2 (no)
DD (1) DD284599A5 (no)
DE (1) DE3863493D1 (no)
DK (1) DK175285B1 (no)
EG (1) EG18919A (no)
ES (1) ES2022988B3 (no)
FI (1) FI94025C (no)
GR (1) GR3002260T3 (no)
IE (1) IE61123B1 (no)
IL (1) IL86631A (no)
MY (1) MY101285A (no)
NO (1) NO176162C (no)
NZ (1) NZ224981A (no)
PH (1) PH25174A (no)
PT (1) PT87701B (no)
RU (1) RU2072835C1 (no)
YU (1) YU46569B (no)
ZA (1) ZA884163B (no)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US4981870A (en) * 1989-03-07 1991-01-01 Pfizer Inc. Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
US6361795B1 (en) * 1989-09-05 2002-03-26 Alza Corporation Method for lowering blood glucose
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5256440A (en) * 1992-06-22 1993-10-26 Merck & Co., Inc. Process for producing a tablet core aperture
US5343550A (en) * 1993-02-25 1994-08-30 The United States Of America As Represented By The United States National Aeronautics And Space Administration Transversely polarized source cladding for an optical fiber
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
NZ283160A (en) 1994-05-06 1998-07-28 Pfizer Azithromycin in a controlled release dosage form for treating microbiol infections
US5534263A (en) * 1995-02-24 1996-07-09 Alza Corporation Active agent dosage form comprising a matrix and at least two insoluble bands
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
HU225819B1 (en) 1996-06-17 2007-10-29 Janssen Pharmaceutica Nv Biconvex rapidly disintegrating dosage forms
JP3148256B2 (ja) * 1996-07-08 2001-03-19 エドワード メンデル カンパニー．，インコーポレーテッド 高用量難溶性薬物用持続放出マトリックス
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
SK180499A3 (en) 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6365183B1 (en) * 1998-05-07 2002-04-02 Alza Corporation Method of fabricating a banded prolonged release active agent dosage form
ATE391495T1 (de) * 1999-09-30 2008-04-15 Penwest Pharmaceuticals Co Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
RU2200002C1 (ru) * 2001-07-30 2003-03-10 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Твердая фармацевтическая композиция и способ ее получения
RU2190392C1 (ru) * 2001-09-14 2002-10-10 Нестерук Владимир Викторович Фармацевтическая композиция на основе доксазозина
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7122143B2 (en) 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7323192B2 (en) 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
US6837696B2 (en) 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
WO2003026626A2 (en) 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
RU2191573C1 (ru) * 2001-11-14 2002-10-27 Нестерук Владимир Викторович Способ получения антибактериального средства на основе доксициклина
ITMI20020515A1 (it) * 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
CN100335041C (zh) 2002-04-04 2007-09-05 辉瑞产品公司 美味咀嚼片剂
CN100435880C (zh) * 2003-02-28 2008-11-26 微创医疗器械(上海)有限公司 一种药物洗脱介入医疗器械及其制备方法
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP3811127B2 (ja) * 2003-01-30 2006-08-16 株式会社東芝 情報記録装置及び情報記録方法
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
US8734850B2 (en) * 2003-11-25 2014-05-27 Flamel Technologies Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
CA2549935A1 (en) * 2003-12-17 2005-07-07 Pfizer Products Inc. Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen
US9492541B2 (en) * 2004-09-14 2016-11-15 Sovereign Pharmaceuticals, Llc Phenylepherine containing dosage form
EP1781264B1 (en) 2004-08-04 2013-07-24 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
WO2006102673A1 (en) * 2005-03-24 2006-09-28 E. I. Du Pont De Nemours And Company Transponder overmolded with ethylene copolymers
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
EP1859788A1 (en) * 2006-05-24 2007-11-28 Abbott GmbH & Co. KG Production of enveloped pharmaceutical dosage forms
WO2008093578A1 (ja) * 2007-01-30 2008-08-07 Olympus Medical Systems Corp. 管腔通過確認装置、その溶解方法および製造方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
RU2012115855A (ru) * 2009-09-22 2013-10-27 Евоник Дегусса Корпорейшн Имплантируемые устройства для модулирования профилей высвобождения биологически активного компонента
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
JP5879979B2 (ja) 2011-11-30 2016-03-08 ブラザー工業株式会社 分離片ユニットおよびシート搬送装置
GB2498999A (en) 2012-02-02 2013-08-07 Siemens Plc Mechanical superconducting switch
CN104490838B (zh) * 2014-11-20 2017-03-01 河北医科大学 一种骨架型缓控释片剂及其制备方法和应用
USD765828S1 (en) 2015-02-19 2016-09-06 Crossford International, Llc Chemical tablet
USD789514S1 (en) * 2016-06-01 2017-06-13 David Hill Injectable tablet
US10583089B2 (en) 2016-07-19 2020-03-10 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
WO2018017553A2 (en) * 2016-07-19 2018-01-25 Johnson & Johnson Consumer Inc. Tablets having discontinuous coated regions
KR20210013089A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
KR20210013088A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP3803866A4 (en) 2018-05-24 2022-03-16 Nureva Inc. METHOD, APPARATUS, AND COMPUTER READABLE MATERIALS FOR MANAGING SEMI-CONSTANT (PERSISTENT) SOUND SOURCES IN MICROPHONE CATCH/HOME AREAS
US12163326B1 (en) * 2019-10-01 2024-12-10 NeverClog, LLC System for capturing and destroying hair or waste within a commercial shower drain
AU2021217209A1 (en) 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
BR112023022439A2 (pt) 2021-04-26 2023-12-26 Celanese Eva Performance Polymers Llc Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular
USD979043S1 (en) * 2021-04-29 2023-02-21 Kurt A. Van Tine Tablet

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2539036A (en) * 1946-04-25 1951-01-23 Schwab Fritz Arrangement for applying chemicals and minerals for therapeutical purposes
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB972128A (en) * 1960-01-21 1964-10-07 Wellcome Found Pellets for supplying biologically active substances to ruminants and the manufacture of such pellets
NL175029C (nl) * 1970-12-23 1984-09-17 Boehringer Sohn Ingelheim Depotdragee, die bekleed is met een onoplosbare en onverteerbare schaal, die op een of meer plaatsen een uitsparing vertoont.
AT341100B (de) * 1972-12-27 1978-01-25 Alza Corp Verfahren zur herstellung eines korpers bzw. einer vorrichtung zur abgabe mit gesteuerter geschwindigkeit eines aktiven mittels
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
CH646330A5 (en) * 1980-05-21 1984-11-30 Ciba Geigy Ag Divisible slow-release pharmaceutical tablets
AU8363582A (en) * 1981-06-15 1982-12-23 Bally Manufacturing Corp. Surface projectile game
GB2110524B (en) * 1981-12-05 1985-06-12 Ronald Poppleton Hill Apparatus for dispensing a volatile material
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
AU591171B2 (en) * 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
IN162525B (no) * 1984-02-08 1988-06-04 Pfizer
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4673565A (en) * 1985-05-03 1987-06-16 E. I. Du Pont De Nemours And Company Pharmaceutical compositions containing hollow fine tubular drug delivery systems
GB8514666D0 (en) * 1985-06-11 1985-07-10 Coopers Animal Health Agent delivery systems
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation

Also Published As

Publication number Publication date
PT87701B (pt) 1992-09-30
GR3002260T3 (en) 1992-12-30
CN1018151B (zh) 1992-09-09
CA1326821C (en) 1994-02-08
NO176162B (no) 1994-11-07
FI882780L (fi) 1988-12-12
IL86631A0 (en) 1988-11-30
KR900004092B1 (ko) 1990-06-15
DK318788D0 (da) 1988-06-10
YU112688A (en) 1990-04-30
US4792448A (en) 1988-12-20
NZ224981A (en) 1991-07-26
CN1030358A (zh) 1989-01-18
MY101285A (en) 1991-08-17
CS401188A2 (en) 1990-08-14
FI94025B (fi) 1995-03-31
FI882780A0 (fi) 1988-06-10
JPH0688900B2 (ja) 1994-11-09
EP0294993B1 (en) 1991-07-03
CS274431B2 (en) 1991-04-11
IL86631A (en) 1991-09-16
RU2072835C1 (ru) 1997-02-10
IE881763L (en) 1988-12-11
YU46569B (sh) 1993-11-16
JPS649930A (en) 1989-01-13
PH25174A (en) 1991-03-27
DD284599A5 (de) 1990-11-21
IE61123B1 (en) 1994-10-05
AU1761488A (en) 1988-12-15
NO882565D0 (no) 1988-06-10
ATE64850T1 (de) 1991-07-15
KR890000081A (ko) 1989-03-11
ZA884163B (en) 1990-02-28
DK318788A (da) 1989-02-06
FI94025C (fi) 1995-07-10
EP0294993A1 (en) 1988-12-14
ES2022988B3 (es) 1991-12-16
DE3863493D1 (de) 1991-08-08
AU598938B2 (en) 1990-07-05
NO882565L (no) 1988-12-12
EG18919A (en) 1994-06-30
DK175285B1 (da) 2004-08-09
PT87701A (pt) 1988-07-01

Similar Documents

Publication Publication Date Title
NO176162C (no) Fremgangsmåte for fremstilling av en anordning for kontrollert medikamentavgivelse
FI873822A0 (fi) Väline vaikuttavan aineen vapauttamiseksi kontrolloidusti ja menetelmä sen valmistamiseksi
NO923756L (no) Osmotisk doseringssystem for avgivelse av vaeskeformig medikament
PT88854A (pt) Sistema para a libertacao controlada dum medicamento benefico
FR2622799B1 (fr) Forme de dosage pharmaceutique a liberation controlee et procede pour sa preparation
KR890701165A (ko) 유익한 약품을 정맥내 수액 시스템내에 도입하기 위한 약품통과 연접기
ES2021028B3 (es) Dispositivo para liberacion de farmacos en 2 etapas.
IT8720708A0 (it) Sistema terapeutico per la cessione controllata di farmaci.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees